Charles Koller

20.1k citations
239 papers · 15.1k · 4 hit papers · h-index 66

Impact in

  • Genetics top 0.02%
    • Chronic Lymphocytic Leukemia Research
  • Hematology top 0.05%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Hematopoietic Stem Cell Transplantation

Papers in

    • Chronic Lymphocytic Leukemia Research 110
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 14
    • Chronic Myeloid Leukemia Treatments 59
    • Acute Myeloid Leukemia Research 58

Charles Koller

236 papers receiving 14.7k citations

Charles Koller's Hit Papers

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia 2005 · 705 citations
7050+9+19Years since publication250500750

Peers

Charles Koller
Comparison fields: 5 of 123
  • Genetics 6.9k
  • Hematology 6.2k
  • Pathology and Forensic Medicine 3.9k
  • Immunology 2.8k
  • Oncology 2.5k
Replace Alessandra Ferrajoli with:
Alessandra Ferrajoli United States
Tadeusz Robak Poland
S Tura Italy
Dieter Hoelzer Germany
David C. Linch United Kingdom
Georges Flandrin France
Jürgen Finke Germany
Jan A. Burger United States
Steven Coutré United States
Alan F. List United States
Charles Koller relative to Alessandra Ferrajoli United States Alessandra Ferrajoli's profile →
Citations per field
00.5×1.5×
Alessandra Ferrajoli · 1×
Citations per year

Countries citing papers authored by Charles Koller

Since Specialization
Citations

This map shows the geographic impact of Charles Koller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Koller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Koller more than expected).

Fields of papers citing papers by Charles Koller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Koller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Koller. The network helps show where Charles Koller may publish in the future.

Co-authors

The 25 scholars most cited alongside Charles Koller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles Koller Line = papers co-authored together Charles Koller links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
Hit paper breakdown →
1997907
2
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
Hit paper breakdown →
2005705
3
Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia
Hit paper breakdown →
2000592
4
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
Hit paper breakdown →
2000561
5 2004461
6 2005401
7 1989383
8 2006380
9 1998344
10 1991299
11 2001271
12 2007253
13 1994244
14 1993232
15 1989216
16 1991206
17 2003201
18 2009195
19 1993195
20 2003178

About Charles Koller

Charles Koller is a scholar working on Genetics, Hematology, Public Health, Environmental and Occupational Health, Molecular Biology and Pathology and Forensic Medicine, having authored 239 papers that have together received 15.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (110 papers), Chronic Myeloid Leukemia Treatments (59 papers), Acute Myeloid Leukemia Research (58 papers), Acute Lymphoblastic Leukemia research (47 papers), Lymphoma Diagnosis and Treatment (44 papers), Immunodeficiency and Autoimmune Disorders (22 papers), Eosinophilic Disorders and Syndromes (16 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers). The work is most often cited by research in Genetics (6.9k citations), Hematology (6.2k citations), Pathology and Forensic Medicine (3.9k citations), Immunology (2.8k citations) and Oncology (2.5k citations). Charles Koller has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Hagop M. Kantarjian, Michael J. Keating, Jörge E. Cortes, Susan O’Brien, Francis J. Giles, Elihu H. Estey, Deborah A. Thomas, Miloslav Beran, Susan Lerner and Stefan Faderl. Their work appears in journals such as Blood, Cancer, Journal of Clinical Oncology, Leukemia and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact